The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Williams Richard C since 2005.
The trader's CIK number is 1216989.
At the time of the last reporting, Williams Richard C was the Director of Adamis Pharmaceuticals Corp. (stock ticker symbol ADMP).
Also see all insider trading activities at Adamis Pharmaceuticals Corp.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2019 | ADMP | 50,000 | $78,500 | 0 | $0 | 0 | $0 |
| 2015 | ADMP | 9,800 | $31,928 | 0 | $0 | 0 | $0 |
| 2006 | ADMP | 0 | $0 | 10,000 | $5,400,000 | 0 | $0 |
| 2005 | ADMP | 20,000 | $42,600 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2008 | ISTA | 84,600 | $70,433 | 0 | $0 | 0 | $0 |
| 2005 | ISTA | 300 | $2,394 | 0 | $0 | 0 | $0 |
| 2005 | ISTA | 25,000 | $204,674 | 0 | $0 | 0 | $0 |
1. Adamis Pharmaceuticals Corp (ADMP)
2. Ista Pharmaceuticals Inc (ISTA)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-05-24 | ADMP | Buy | 50,000 | 1.57 | 78,500 |
| 2015-08-13 | ADMP | Buy | 9,800 | 3.26 | 31,928 |
| 2006-12-27 | CLGY | Sale | 10,000 | 540.00 | 5,400,000 |
| 2005-05-12 | CLGY | Buy | 20,000 | 2.13 | 42,600 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2008-12-15 | ISTA | Buy | 200 | .82 | 164 |
| 2008-12-16 | ISTA | Buy | 6,225 | .80 | 4,980 |
| 2008-12-10 | ISTA | Buy | 13,575 | .78 | 10,588 |
| 2008-12-11 | ISTA | Buy | 30,000 | .98 | 29,340 |
| 2008-12-09 | ISTA | Buy | 34,600 | .73 | 25,361 |
| 2005-05-16 | ISTA | Buy | 300 | 7.98 | 2,394 |
| 2005-05-16 | ISTA | Buy | 25,000 | 8.19 | 204,674 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Williams Richard C (Director of Adamis Pharmaceuticals Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.